Related Experiment Video

Updated: Jun 19, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Proteomics, pathway array and signaling network-based medicine in cancer

David Y Zhang1, Fei Ye, Ling Gao

  • 1Department of Pathology, Mount Sinai School of Medicine, New York, NY, USA. david.zhang@mssm.edu.

Cell Division
|October 30, 2009
PubMed

Insights

Identifying cancer

Area of Science:

  • Oncology
  • Bioinformatics
  • Molecular Biology

Background:

  • Cancer arises from disrupted cellular signaling networks due to genetic and epigenetic changes.
  • Understanding these molecular alterations is key to cancer mechanism and personalized medicine.
  • Technological advancements enable global assessment of genetic, epigenetic, and proteomic changes in cancer.

Purpose of the Study:

  • To review and compare Pathway Array analysis with other proteomic methods for cancer signaling network analysis.
  • To highlight the utility of signaling network signatures as cancer biomarkers for diagnosis, prognosis, and therapy.
  • To emphasize the growing role of bioinformatics in constructing complex signaling networks for clinical applications.

Main Methods:

  • Review of existing literature on proteomic approaches for cancer signaling network analysis.
  • Comparison of Pathway Array analysis with other proteomic techniques.
  • Discussion of bioinformatics tools for network construction and analysis.

Main Results:

  • Pathway Array analysis offers a valuable approach for studying cancer protein networks.
  • Signaling network signatures can serve as effective biomarkers for cancer diagnosis, prognosis, and therapeutic targeting.
  • Bioinformatics facilitates the construction of intricate signaling networks essential for future personalized medicine.

Conclusions:

  • Pathway Array analysis is a powerful tool for dissecting cancer signaling pathways.
  • Network-based signatures hold significant promise for advancing personalized cancer care.
  • The integration of bioinformatics and network analysis is crucial for future cancer research and treatment.

More Related Videos

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...